Page last updated: 2024-11-11

bts 67582

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9885406
SCHEMBL ID2908206
SCHEMBL ID2908209
MeSH IDM0244570

Synonyms (15)

Synonym
SCHEMBL2908206
SCHEMBL2908209
C83HW55OVT ,
guanidine, n,n-dimethyl-n'-(2-(4-morpholinyl)phenyl)-, (2e)-2-butenedioate (1:1)
bts-67-582
161748-40-9
1,1-dimethyl-2-(2-(4-morpholinophenyl))guanidine monofumarate
guanidine, n,n-dimethyl-n'-(2-(4-morpholinyl)phenyl)-, (e)-2-butenedioate (1:1)
bts-67582
unii-c83hw55ovt
1,1-dimethyl-2-(2-morpholinophenyl)guanidine monofumarate
bts 67582
bts 67 582
(e)-but-2-enedioic acid;1,1-dimethyl-2-(2-morpholin-4-ylphenyl)guanidine
Q27275309

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" This was associated with a 3 fold increase in insulin concentrations, even in the presence of adrenaline at a dosage which inhibits glucose-induced insulin release."( Glucose-lowering effect of BTS 67 582.
Bailey, CJ; Page, T, 1997
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (71.43)18.2507
2000's4 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.34 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (14.29%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (78.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]